Discovery of a sensitive, selective, and tightly binding fluorogenic substrate of bovine plasma amine oxidase
- PMID: 19053593
- PMCID: PMC2659760
- DOI: 10.1021/jo8018945
Discovery of a sensitive, selective, and tightly binding fluorogenic substrate of bovine plasma amine oxidase
Abstract
We report a novel fluorogenic substrate of bovine plasma amine oxidase (BPAO), namely, (2-(6-(aminomethyl)naphthalen-2-yloxy)ethyl)trimethylammonium (ANETA), which displays extremely tight binding to BPAO (K(m) 183 +/- 14 nM) and yet is metabolized fairly quickly (k(cat) 0.690 +/- 0.010 s(-1)), with the aldehyde turnover product (2-(6-formylnaphthalen-2-yloxy)ethyl)trimethylammonium serving as a real time reporting fluorophore of the enzyme activity. This allowed for the development of a fluorometric noncoupled assay that is 2 orders of magnitude more sensitive than the spectrophotometric benzylamine assay. The discovery of ANETA involved elaboration of the lead compound 6-methoxy-2-naphthalenemethaneamine by structure-based design, which recognized the ancillary cation binding site of BPAO as the most significant structural features controlling binding affinity. Structure-based design further ensured a high level of selectivity: ANETA is a good substrate of BPAO but is not a substrate of either porcine kidney diamine oxidase (pkDAO) or rat liver monoamine oxidase (MAO-B). ANETA represents the first highly sensitive, selective, and tight binding fluorogenic substrate of a copper amine oxidase that is able to respond directly to the enzyme activity in real time.
Figures












References
-
- Knowles PF, Dooley DM. In: Metal Ions in Biological Systems. Sigel H, Sigel A, editors. Vol. 30. New York: Marcel Dekker; 1994. pp. 361–403.
- Klinman JP. Chem. Rev. 1996;96:2541–2561. - PubMed
-
-
For recent reviews, see Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D. Biochim. Biophys. Acta. 2003;1647:193–199.
- Boomsma F, Bhaggoe UM, van der Houwen AM, van den Meiracker AH. Biochim. Biophys. Acta. 2003;1647:48–54. - PubMed
- O’Sullivan J, Unzeta M, Healy J, O’Sullivan MI, Davey G, Tipton KF. Neurotoxicology. 2004;25:303–315. - PubMed
- Matyus P, Dajka-Halasz B, Foldi A, Haider N, Barlocco D, Magyar K. Curr. Med. Chem. 2004;11:1285–1298. - PubMed
- Boomsma F, Hut H, Bagghoe U, van der Houwen A, van den Meiracker A. Med. Sci. Monit. 2005;11:122–126. - PubMed
- Obata T. Life Sci. 2006;79:417–422. - PubMed
- Gong B, Boor PJ. Expert Opin. Drug Metab. Toxicol. 2006;2:559–571. - PubMed
- Lucero HA, Kagan HM. Cell Mol. Life Sci. 2006;63:2304–2316. - PMC - PubMed
- McDonald IA, Foot J, Yin P, Flening E, van Dam EM. Ann. Rep. Med. Chem. 2007;42:229–243.
- Dunkel P, Gelain A, Barlocco D, Haider N, Gyires K, Sperlagh B, Magyar K, Maccioni E, Fadda A, Matyus P. Curr. Med. Chem. 2008;15:1827–1839. - PubMed
-
-
-
For a recent review, see Dubois JL, Klinman JP. Arch. Biochem. Biophys. 2005;433:255–265.
-
-
- Mure M, Mills SA, Klinman JP. Biochemistry. 2002;41:9269–9278. - PubMed